Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
出版信息
JAMA. 1990 Aug 8;264(6):752-4.
PMID:2374280
Abstract
摘要
相似文献
1
2
[Intracavernous pharmacotherapy for organic impotence in the elderly].[老年器质性阳痿的海绵体内药物治疗]
Harefuah. 1990 Aug;119(3-4):66-7.
3
[Intracavernous injection of vasoactive drugs for treating erectile impotence].[海绵体内注射血管活性药物治疗勃起功能障碍]
Hinyokika Kiyo. 1988 Feb;34(2):301-4.
4
Intracavernous injections for impotence.用于治疗阳痿的海绵体内注射
Med Lett Drugs Ther. 1987 Oct 23;29(751):95-6.
5
Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.海绵体内注射血管活性药物，是治疗脊髓损伤患者阳痿的一种替代方法。
Paraplegia. 1986 Oct;24(5):271-5. doi: 10.1038/sc.1986.37.
6
Therapeutic roles of intracavernosal papaverine.海绵体内注射罂粟碱的治疗作用。
Cardiovasc Intervent Radiol. 1988 Aug;11(4):237-9. doi: 10.1007/BF02577009.
7
Pharmacologic erection program for the treatment of male impotence.用于治疗男性阳痿的药物勃起方案。
South Med J. 1987 Apr;80(4):426-7. doi: 10.1097/00007611-198704000-00004.
8
[Intracavernous pharmacotherapy for treatment and evaluation of impotence].[阴茎海绵体内药物治疗用于阳痿的治疗与评估]
Harefuah. 1991 Oct;121(7-8):223-5.
9
[Current role of intracavernous therapy in the treatment of erectile dysfunction].[海绵体内注射疗法在勃起功能障碍治疗中的当前作用]
Arch Esp Urol. 2002 Jun;55(5):475-82.
10
The use of vasoactive agents in the treatment of erectile impotence.血管活性药物在勃起功能障碍治疗中的应用。
N C Med J. 1990 Jun;51(6):295-6.
Zotero 插件